Duncan McLaren

The need for evidence-based clinical research into the therapeutic properties of cannabinoids has long been recognized, but to date, little has been done about it. Greenspace Labs was created to change that. Our goal is to identify human conditions that can benefit from treatment with cannabinoids, develop different formulations, and perform clinical research to determine the effectiveness of those formulations. We are currently working with the FDA to create pathways to bring these formulations to market, either as an OTC, or a prescription treatment.